Business Wire

BearingPoint client success story: JobRad Leasing ensures sustainable business growth through a successful financing transaction

11.12.2024 09:00:00 CET | Business Wire | Press release

Share

BearingPoint assisted JobRad Leasing GmbH in leveraging the Securitization as a Service solution to enhance its data management and reporting capabilities

As society increasingly values sustainability, bicycle mobility is becoming a popular choice for commuting. Another driver of this development is company bike leasing, invented by the Freiburg-based company JobRad. Similar to company car leasing, company bike leasing offers tax advantages that allow employees to save up to 40 percent in cash compared to buying a new bike. With its concept, the industry leader JobRad has so far brought more than 1.5 million people onto bikes. JobRad's central leasing company is the in-house JobRad Leasing GmbH. For refinancing strategies, the company has also been relying on asset-based refinancing for some time.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241211468345/en/

BearingPoint assisted JobRad Leasing GmbH in leveraging the Securitization as a Service solution to enhance its data management and reporting capabilities. (Graphic: Business Wire)

Securitization is key to this type of liquidity management, as it involves pooling financial assets such as loans, leases, or trade receivables and transforming them into a new financial investment product, known as asset-backed commercial paper (ABCP). However, creating a portfolio of eligible assets for ABCP involves managing extensive data from various sources, meeting reporting requirements, and adhering to eligibility criteria. As a result, for its first securitization transaction, the company sought to automate and efficiently develop the asset portfolio while maintaining the feasibility and high level of digitization that characterizes the entire JobRad Group.

Developing bespoke solutions for effective management of securitization transactions

Leveraging its Securitization as a Service solution,BearingPoint assisted JobRad Leasing GmbH in its first securitization transaction. The joint team conducted an interface workshop to identify the data requirements needed to meet market transparency standards. This laid the foundation for comprehensive documentation to pinpoint and evaluate the financial assets to be securitized. In the next step, relevant business logic was defined. Thereafter, BearingPoint configured the technical platform to incorporate JobRad Leasing’s data, business events, and the required types of reporting formats. During the development and testing phase, BearingPoint focused on aligning the reporting capabilities, while ensuring the accuracy and completeness of the data.

Detailed templates were then created for both the functionality and design of all corporate reports related to funding operations, ensuring that compliance standards were met, including reporting, documentation, and disclosure requirements. The project team integrated the securitization platform with the client's existing systems and workflows to enable a smooth transition and maximize operational efficiency. On an ongoing basis, BearingPoint will provide monthly reports throughout the transaction, using data from JobRad Leasing GmbH via the new interface to enable optimal and timely execution of the securitization transaction.

“Data is essential for JobRad to finance its sustainable solutions for eco-mobility in an efficient manner, particularly when it comes to securitization. We are very pleased that BearingPoint’s Securitization as a Service solution enables JobRad to meet the challenging capital market requirements for data quality and data transparency as it contributes to a stable funding, improved liquidity and efficient risk management,” said Donald Wachs, global Leader BearingPoint Products.

Simplifying the complexity of Asset-Based Funding

By using BearingPoint’s Securitization as a Service solution, JobRad Leasing GmbH has enhanced its data management capabilities and can handle effectively the complexities of its first securitization transaction. The highly automated processes have led to substantial improvements in time and resource efficiency. Additionally, the company now benefits from fast access to necessary reports and has shortened the report delivery times.

Moreover, the scalable operations and secure data enable JobRad Leasing GmbH to enhance its liquidity and effectively manage risk. With full visibility into its leasing transaction at all times, the company is able to address compliance and extensive investor transparency requirements, while also meeting the reporting standards set by the European Securities and Markets Authority (ESMA).

“Working with BearingPoint on our first securitization transaction has been a very positive experience for JobRad Leasing GmbH. With BearingPoint's solution, we were able to significantly simplify and streamline our processes and data management to meet our capital markets reporting requirements. As a result, we have been able to further broaden our refinancing base - bringing us one step closer to our goal of putting people on JobRad,” said Benjamin Kräutter, Team Leader Treasury at JobRad.

About JobRad

JobRad Leasing GmbH has been part of the JobRad Group since its market entry in 2019 and, as a bank-independent leasing company, works exclusively with JobRad employers.As one of two possible lessors, JobRad Leasing GmbH is a direct contractual partner of JobRad employers.

About BearingPoint

BearingPoint is an independent management and technology consultancy with European roots and a global reach. The company operates in three business units: Consulting, Products, and Capital. Consulting covers the advisory business with a clear focus on selected business areas. Products provides IP-driven digital assets and managed services for business-critical processes. Capital delivers M&A and transaction services.

BearingPoint’s clients include many of the world’s leading companies and organizations. The firm has a global consulting network with more than 10,000 people and supports clients in over 70 countries, engaging with them to achieve measurable and sustainable success.

BearingPoint is a certified B Corporation, meeting high standards of social and environmental impact.

For more information, please visit:

Homepage: www.bearingpoint.com
Securitization as a Service: www.bearingpoint.services/securitization-as-a-service
LinkedIn: www.linkedin.com/company/bearingpoint
Twitter: @BearingPoint

View source version on businesswire.com: https://www.businesswire.com/news/home/20241211468345/en/

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Yubico Appoints Poupak Modirassari Enbom as Chief Marketing Officer to Accelerate Global Momentum and Drive Market Leadership30.3.2026 15:00:00 CEST | Press release

Yubico (NASDAQ STOCKHOLM: YUBICO), the creator of the most secure passkeys and a leading provider of hardware authentication security keys, today announced the appointment of Poupak Enbom as Chief Marketing Officer (CMO). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330278027/en/ Enbom joins Yubico at a pivotal moment as organizations worldwide accelerate the shift to phishing-resistant authentication and modern identity security in the age of AI. “We’re excited to welcome Poupak to Yubico,” said Jerrod Chong, acting chief executive officer, Yubico. “As the threat landscape evolves with AI-driven attacks and increasing automation, organizations are rethinking how they secure digital identities of both humans and AI agents at scale. She brings a unique combination of technical depth, global leadership, and customer-first mindset that will help us continue to expand our impact and support our customers and partners around

Westinghouse Celebrates Record-breaking 80 Years of Nuclear Fuel Manufacture at Springfields30.3.2026 14:00:00 CEST | Press release

Fuel manufactured at Springfields has generated enough energy to supply the UK’s electricity demand for 26 years, avoiding the emission of nearly 3 billion tonnes of CO2 The Westinghouse Springfields facility in Lancashire, UK, has marked a significant milestone as the oldest continuous nuclear fuel manufacturing site in the world, starting from its original license on the 28th, March 1946. The site was chosen by the UK Government to develop nuclear fuel for the world’s earliest civil nuclear power stations, as well as subsequent Magnox and Advanced Gas Reactors (AGR) reactors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330135973/en/ From left to right: Sophie Lemaire; Marc Chevrel; Rory O'Neill; Craig Boothby; and Robert Gofton, CEO at Nuclear Institute Across the last eight decades, the Springfields site has supported the UK nuclear fleet, manufacturing more than eight million AGR pins, sintering and pressing over 5

HistoSonics Treats First Patients Evaluating the Edison® Histotripsy System for the Treatment of Benign Prostatic Hyperplasia (BPH)30.3.2026 14:00:00 CEST | Press release

HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced the successful treatments of the first patients in WOLVERINE, a prospective feasibility trial evaluating the Edison® Histotripsy System for the treatment of benign prostatic hyperplasia (BPH) at Prince of Wales Hospital in Hong Kong, a teaching hospital for The Chinese University of Hong Kong. The Edison System is a novel, non-invasive, image guided platform that uses the mechanical properties of focused ultrasound, called histotripsy, to destroy unwanted tissue without the need for invasive procedures, and with potentially fewer side effects than traditional, invasive therapies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330349844/en/ HistoSonics Non-Invasive Edison Histotripsy System. Image credit: HistoSonics WOLVERINE is a prospective, multi-center, single-arm feasibility trial designed to evaluate

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye